nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—MPO—Crohn's disease	0.223	0.727	CbGaD
Cisplatin—GSTM1—Azathioprine—Crohn's disease	0.134	0.264	CbGbCtD
Cisplatin—PTGS2—Crohn's disease	0.0837	0.273	CbGaD
Cisplatin—MPO—Mesalazine—Crohn's disease	0.0812	0.16	CbGbCtD
Cisplatin—ABCC5—Mercaptopurine—Crohn's disease	0.0681	0.134	CbGbCtD
Cisplatin—XDH—Azathioprine—Crohn's disease	0.0557	0.11	CbGbCtD
Cisplatin—XDH—Mercaptopurine—Crohn's disease	0.0557	0.11	CbGbCtD
Cisplatin—PTGS2—Balsalazide—Crohn's disease	0.0351	0.0691	CbGbCtD
Cisplatin—PTGS2—Mesalazine—Crohn's disease	0.0281	0.0552	CbGbCtD
Cisplatin—ABCC2—Sulfasalazine—Crohn's disease	0.0159	0.0312	CbGbCtD
Cisplatin—PTGS2—Sulfasalazine—Crohn's disease	0.0157	0.0309	CbGbCtD
Cisplatin—ABCG2—Sulfasalazine—Crohn's disease	0.0143	0.0282	CbGbCtD
Cisplatin—MPO—superior mesenteric artery—Crohn's disease	0.012	0.203	CbGeAlD
Cisplatin—Bone marrow toxicity—Mercaptopurine—Crohn's disease	0.0111	0.148	CcSEcCtD
Cisplatin—ABCB1—Prednisone—Crohn's disease	0.00413	0.00814	CbGbCtD
Cisplatin—Serum amylase increased—Mesalazine—Crohn's disease	0.00412	0.0551	CcSEcCtD
Cisplatin—Azoospermia—Mercaptopurine—Crohn's disease	0.00296	0.0395	CcSEcCtD
Cisplatin—ABCC2—bile—Crohn's disease	0.00264	0.0446	CbGeAlD
Cisplatin—MT1A—mouth—Crohn's disease	0.00216	0.0365	CbGeAlD
Cisplatin—MT2A—gall bladder—Crohn's disease	0.00202	0.0342	CbGeAlD
Cisplatin—SLC31A2—mouth—Crohn's disease	0.00177	0.0299	CbGeAlD
Cisplatin—GSTT1—mouth—Crohn's disease	0.00176	0.0297	CbGeAlD
Cisplatin—Myelosuppression—Mercaptopurine—Crohn's disease	0.0017	0.0227	CcSEcCtD
Cisplatin—Acute leukaemia—Azathioprine—Crohn's disease	0.00166	0.0222	CcSEcCtD
Cisplatin—Renal failure chronic—Mesalazine—Crohn's disease	0.00161	0.0215	CcSEcCtD
Cisplatin—Azoospermia—Mesalazine—Crohn's disease	0.00161	0.0215	CcSEcCtD
Cisplatin—Nephrotoxicity—Mesalazine—Crohn's disease	0.00136	0.0182	CcSEcCtD
Cisplatin—GSTM1—mouth—Crohn's disease	0.0013	0.0219	CbGeAlD
Cisplatin—Skin necrosis—Mesalazine—Crohn's disease	0.00124	0.0165	CcSEcCtD
Cisplatin—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00103	0.0138	CcSEcCtD
Cisplatin—NQO1—gall bladder—Crohn's disease	0.00102	0.0173	CbGeAlD
Cisplatin—Myelosuppression—Azathioprine—Crohn's disease	0.00101	0.0135	CcSEcCtD
Cisplatin—MT2A—skin of body—Crohn's disease	0.000994	0.0168	CbGeAlD
Cisplatin—MT1A—digestive system—Crohn's disease	0.000955	0.0161	CbGeAlD
Cisplatin—Liver injury—Mercaptopurine—Crohn's disease	0.000947	0.0127	CcSEcCtD
Cisplatin—ABCC3—gall bladder—Crohn's disease	0.000916	0.0155	CbGeAlD
Cisplatin—GSTP1—gall bladder—Crohn's disease	0.000912	0.0154	CbGeAlD
Cisplatin—Amylase increased—Mesalazine—Crohn's disease	0.000909	0.0121	CcSEcCtD
Cisplatin—NQO1—mouth—Crohn's disease	0.000908	0.0154	CbGeAlD
Cisplatin—ATP7A—epithelium—Crohn's disease	0.000905	0.0153	CbGeAlD
Cisplatin—SLC31A2—mammalian vulva—Crohn's disease	0.000891	0.0151	CbGeAlD
Cisplatin—CYP4A11—digestive system—Crohn's disease	0.000879	0.0149	CbGeAlD
Cisplatin—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.000859	0.0115	CcSEcCtD
Cisplatin—Glucose tolerance impaired—Prednisone—Crohn's disease	0.00085	0.0114	CcSEcCtD
Cisplatin—Ulcer—Mercaptopurine—Crohn's disease	0.000843	0.0113	CcSEcCtD
Cisplatin—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.000812	0.0108	CcSEcCtD
Cisplatin—GSTP1—mouth—Crohn's disease	0.000811	0.0137	CbGeAlD
Cisplatin—MT2A—lymphoid tissue—Crohn's disease	0.000805	0.0136	CbGeAlD
Cisplatin—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.000797	0.0106	CcSEcCtD
Cisplatin—MT2A—digestive system—Crohn's disease	0.000795	0.0134	CbGeAlD
Cisplatin—GSTT1—lymphoid tissue—Crohn's disease	0.000788	0.0133	CbGeAlD
Cisplatin—ATP7A—mammalian vulva—Crohn's disease	0.000785	0.0133	CbGeAlD
Cisplatin—Memory loss—Prednisone—Crohn's disease	0.000779	0.0104	CcSEcCtD
Cisplatin—GSTT1—digestive system—Crohn's disease	0.000778	0.0132	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—Crohn's disease	0.000763	0.0129	CbGeAlD
Cisplatin—Nephropathy toxic—Mesalazine—Crohn's disease	0.000753	0.0101	CcSEcCtD
Cisplatin—Papilloedema—Prednisone—Crohn's disease	0.00072	0.00961	CcSEcCtD
Cisplatin—GSTM1—skin of body—Crohn's disease	0.000717	0.0121	CbGeAlD
Cisplatin—SOD1—mammalian vulva—Crohn's disease	0.000687	0.0116	CbGeAlD
Cisplatin—SLC31A1—mammalian vulva—Crohn's disease	0.00067	0.0113	CbGeAlD
Cisplatin—XDH—mammalian vulva—Crohn's disease	0.000661	0.0112	CbGeAlD
Cisplatin—Hepatotoxicity—Azathioprine—Crohn's disease	0.000615	0.00821	CcSEcCtD
Cisplatin—SLC31A1—digestive system—Crohn's disease	0.000587	0.00993	CbGeAlD
Cisplatin—GSTM1—lymphoid tissue—Crohn's disease	0.00058	0.00981	CbGeAlD
Cisplatin—XDH—digestive system—Crohn's disease	0.00058	0.00981	CbGeAlD
Cisplatin—GSTM1—digestive system—Crohn's disease	0.000573	0.00969	CbGeAlD
Cisplatin—Liver injury—Azathioprine—Crohn's disease	0.000565	0.00754	CcSEcCtD
Cisplatin—Hepatotoxicity—Mesalazine—Crohn's disease	0.00056	0.00748	CcSEcCtD
Cisplatin—MT1A—lymph node—Crohn's disease	0.000545	0.00922	CbGeAlD
Cisplatin—Rhinorrhoea—Mesalazine—Crohn's disease	0.000534	0.00713	CcSEcCtD
Cisplatin—NQO1—epithelium—Crohn's disease	0.000528	0.00893	CbGeAlD
Cisplatin—Breast disorder—Mercaptopurine—Crohn's disease	0.000523	0.00698	CcSEcCtD
Cisplatin—Liver injury—Mesalazine—Crohn's disease	0.000514	0.00687	CcSEcCtD
Cisplatin—NQO1—smooth muscle tissue—Crohn's disease	0.000509	0.0086	CbGeAlD
Cisplatin—NQO1—skin of body—Crohn's disease	0.000502	0.00849	CbGeAlD
Cisplatin—Tenderness—Mesalazine—Crohn's disease	0.000496	0.00662	CcSEcCtD
Cisplatin—Pancreatitis—Mercaptopurine—Crohn's disease	0.00049	0.00655	CcSEcCtD
Cisplatin—ATP7B—lymph node—Crohn's disease	0.000489	0.00826	CbGeAlD
Cisplatin—MPO—epithelium—Crohn's disease	0.000485	0.00821	CbGeAlD
Cisplatin—Hepatocellular injury—Azathioprine—Crohn's disease	0.000475	0.00634	CcSEcCtD
Cisplatin—Pancytopenia—Mercaptopurine—Crohn's disease	0.000475	0.00634	CcSEcCtD
Cisplatin—GSTP1—epithelium—Crohn's disease	0.000472	0.00798	CbGeAlD
Cisplatin—MPO—skin of body—Crohn's disease	0.000462	0.00781	CbGeAlD
Cisplatin—NQO1—mammalian vulva—Crohn's disease	0.000458	0.00775	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—Crohn's disease	0.000455	0.00769	CbGeAlD
Cisplatin—SLC22A2—digestive system—Crohn's disease	0.000455	0.00769	CbGeAlD
Cisplatin—GSTP1—skin of body—Crohn's disease	0.000449	0.00759	CbGeAlD
Cisplatin—SLC31A2—lymph node—Crohn's disease	0.000446	0.00755	CbGeAlD
Cisplatin—Stomatitis—Mercaptopurine—Crohn's disease	0.000435	0.0058	CcSEcCtD
Cisplatin—Hepatocellular injury—Mesalazine—Crohn's disease	0.000433	0.00578	CcSEcCtD
Cisplatin—PTGS2—gall bladder—Crohn's disease	0.000426	0.0072	CbGeAlD
Cisplatin—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000422	0.00563	CcSEcCtD
Cisplatin—Skin exfoliation—Mesalazine—Crohn's disease	0.000413	0.00552	CcSEcCtD
Cisplatin—GSTP1—mammalian vulva—Crohn's disease	0.000409	0.00692	CbGeAlD
Cisplatin—Neuropathy—Mesalazine—Crohn's disease	0.000406	0.00542	CcSEcCtD
Cisplatin—NQO1—digestive system—Crohn's disease	0.000402	0.00679	CbGeAlD
Cisplatin—ATP7A—lymph node—Crohn's disease	0.000393	0.00665	CbGeAlD
Cisplatin—Febrile neutropenia—Prednisone—Crohn's disease	0.000381	0.00508	CcSEcCtD
Cisplatin—PTGS2—mouth—Crohn's disease	0.000378	0.0064	CbGeAlD
Cisplatin—MPO—lymphoid tissue—Crohn's disease	0.000374	0.00632	CbGeAlD
Cisplatin—Optic neuritis—Prednisone—Crohn's disease	0.000372	0.00497	CcSEcCtD
Cisplatin—MPO—digestive system—Crohn's disease	0.000369	0.00625	CbGeAlD
Cisplatin—GSTP1—lymphoid tissue—Crohn's disease	0.000363	0.00615	CbGeAlD
Cisplatin—Immune system disorder—Mercaptopurine—Crohn's disease	0.000362	0.00483	CcSEcCtD
Cisplatin—ABCC3—digestive system—Crohn's disease	0.000361	0.0061	CbGeAlD
Cisplatin—GSTP1—digestive system—Crohn's disease	0.000359	0.00607	CbGeAlD
Cisplatin—Alopecia—Mercaptopurine—Crohn's disease	0.000354	0.00472	CcSEcCtD
Cisplatin—Deafness—Mesalazine—Crohn's disease	0.000351	0.00469	CcSEcCtD
Cisplatin—Malnutrition—Mercaptopurine—Crohn's disease	0.000349	0.00465	CcSEcCtD
Cisplatin—SOD1—lymph node—Crohn's disease	0.000344	0.00582	CbGeAlD
Cisplatin—Renal failure acute—Mesalazine—Crohn's disease	0.00034	0.00454	CcSEcCtD
Cisplatin—SLC31A1—lymph node—Crohn's disease	0.000335	0.00567	CbGeAlD
Cisplatin—GSTM1—lymph node—Crohn's disease	0.000327	0.00554	CbGeAlD
Cisplatin—Anaemia—Mercaptopurine—Crohn's disease	0.000322	0.0043	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000314	0.00419	CcSEcCtD
Cisplatin—Leukopenia—Mercaptopurine—Crohn's disease	0.000312	0.00417	CcSEcCtD
Cisplatin—Face oedema—Mesalazine—Crohn's disease	0.000303	0.00405	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000295	0.00393	CcSEcCtD
Cisplatin—Blood creatinine increased—Mesalazine—Crohn's disease	0.000294	0.00393	CcSEcCtD
Cisplatin—Pancreatitis—Azathioprine—Crohn's disease	0.000292	0.0039	CcSEcCtD
Cisplatin—Necrosis—Prednisone—Crohn's disease	0.000292	0.00389	CcSEcCtD
Cisplatin—Abscess—Prednisone—Crohn's disease	0.000289	0.00386	CcSEcCtD
Cisplatin—ABCC2—digestive system—Crohn's disease	0.000288	0.00487	CbGeAlD
Cisplatin—Orthostatic hypotension—Mesalazine—Crohn's disease	0.000287	0.00383	CcSEcCtD
Cisplatin—Abdominal discomfort—Azathioprine—Crohn's disease	0.000286	0.00382	CcSEcCtD
Cisplatin—Oedema—Mercaptopurine—Crohn's disease	0.000284	0.0038	CcSEcCtD
Cisplatin—Breast disorder—Mesalazine—Crohn's disease	0.000284	0.00379	CcSEcCtD
Cisplatin—Pancytopenia—Azathioprine—Crohn's disease	0.000283	0.00378	CcSEcCtD
Cisplatin—Cramp muscle—Mesalazine—Crohn's disease	0.000283	0.00378	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000283	0.00378	CcSEcCtD
Cisplatin—Nasopharyngitis—Mesalazine—Crohn's disease	0.000281	0.00375	CcSEcCtD
Cisplatin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000278	0.00372	CcSEcCtD
Cisplatin—Skin disorder—Mercaptopurine—Crohn's disease	0.000276	0.00369	CcSEcCtD
Cisplatin—BCHE—smooth muscle tissue—Crohn's disease	0.000275	0.00466	CbGeAlD
Cisplatin—BCHE—skin of body—Crohn's disease	0.000272	0.0046	CbGeAlD
Cisplatin—Anorexia—Mercaptopurine—Crohn's disease	0.000271	0.00362	CcSEcCtD
Cisplatin—Pancreatitis—Mesalazine—Crohn's disease	0.000266	0.00355	CcSEcCtD
Cisplatin—Abdominal discomfort—Mesalazine—Crohn's disease	0.00026	0.00348	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000259	0.00346	CcSEcCtD
Cisplatin—Pancytopenia—Mesalazine—Crohn's disease	0.000258	0.00344	CcSEcCtD
Cisplatin—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000251	0.00336	CcSEcCtD
Cisplatin—BCHE—mammalian vulva—Crohn's disease	0.000248	0.00419	CbGeAlD
Cisplatin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000247	0.0033	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000246	0.00328	CcSEcCtD
Cisplatin—ABCC5—lymph node—Crohn's disease	0.000245	0.00415	CbGeAlD
Cisplatin—CYP2B6—skin of body—Crohn's disease	0.000242	0.0041	CbGeAlD
Cisplatin—Ulcer—Prednisone—Crohn's disease	0.000242	0.00323	CcSEcCtD
Cisplatin—ABCG2—mammalian vulva—Crohn's disease	0.00024	0.00405	CbGeAlD
Cisplatin—Renal failure—Mesalazine—Crohn's disease	0.000238	0.00318	CcSEcCtD
Cisplatin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000237	0.00317	CcSEcCtD
Cisplatin—Stomatitis—Mesalazine—Crohn's disease	0.000236	0.00315	CcSEcCtD
Cisplatin—Conjunctivitis—Mesalazine—Crohn's disease	0.000235	0.00314	CcSEcCtD
Cisplatin—NQO1—lymph node—Crohn's disease	0.000229	0.00388	CbGeAlD
Cisplatin—Hiccups—Prednisone—Crohn's disease	0.000229	0.00306	CcSEcCtD
Cisplatin—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000229	0.00306	CcSEcCtD
Cisplatin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000225	0.003	CcSEcCtD
Cisplatin—PTGS2—epithelium—Crohn's disease	0.00022	0.00372	CbGeAlD
Cisplatin—Skin exfoliation—Prednisone—Crohn's disease	0.000219	0.00292	CcSEcCtD
Cisplatin—BCHE—digestive system—Crohn's disease	0.000217	0.00368	CbGeAlD
Cisplatin—Fluid retention—Prednisone—Crohn's disease	0.000217	0.0029	CcSEcCtD
Cisplatin—Immune system disorder—Azathioprine—Crohn's disease	0.000215	0.00288	CcSEcCtD
Cisplatin—Mediastinal disorder—Azathioprine—Crohn's disease	0.000215	0.00287	CcSEcCtD
Cisplatin—Neuropathy—Prednisone—Crohn's disease	0.000215	0.00287	CcSEcCtD
Cisplatin—Urinary tract disorder—Mesalazine—Crohn's disease	0.000215	0.00287	CcSEcCtD
Cisplatin—Connective tissue disorder—Mesalazine—Crohn's disease	0.000214	0.00285	CcSEcCtD
Cisplatin—Arrhythmia—Azathioprine—Crohn's disease	0.000213	0.00285	CcSEcCtD
Cisplatin—Urethral disorder—Mesalazine—Crohn's disease	0.000213	0.00284	CcSEcCtD
Cisplatin—PTGS2—smooth muscle tissue—Crohn's disease	0.000212	0.00359	CbGeAlD
Cisplatin—MPO—lymph node—Crohn's disease	0.000211	0.00357	CbGeAlD
Cisplatin—Alopecia—Azathioprine—Crohn's disease	0.000211	0.00281	CcSEcCtD
Cisplatin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00021	0.0028	CcSEcCtD
Cisplatin—PTGS2—skin of body—Crohn's disease	0.000209	0.00354	CbGeAlD
Cisplatin—ABCC3—lymph node—Crohn's disease	0.000206	0.00348	CbGeAlD
Cisplatin—GSTP1—lymph node—Crohn's disease	0.000205	0.00347	CbGeAlD
Cisplatin—Eye disorder—Mesalazine—Crohn's disease	0.000203	0.00271	CcSEcCtD
Cisplatin—Tinnitus—Mesalazine—Crohn's disease	0.000203	0.00271	CcSEcCtD
Cisplatin—Cardiac disorder—Mesalazine—Crohn's disease	0.000202	0.00269	CcSEcCtD
Cisplatin—Immune system disorder—Mesalazine—Crohn's disease	0.000196	0.00262	CcSEcCtD
Cisplatin—CYP2B6—lymphoid tissue—Crohn's disease	0.000196	0.00332	CbGeAlD
Cisplatin—Mediastinal disorder—Mesalazine—Crohn's disease	0.000196	0.00261	CcSEcCtD
Cisplatin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000195	0.0026	CcSEcCtD
Cisplatin—CYP2B6—digestive system—Crohn's disease	0.000194	0.00328	CbGeAlD
Cisplatin—Ill-defined disorder—Azathioprine—Crohn's disease	0.000193	0.00257	CcSEcCtD
Cisplatin—Alopecia—Mesalazine—Crohn's disease	0.000192	0.00256	CcSEcCtD
Cisplatin—Anaemia—Azathioprine—Crohn's disease	0.000192	0.00256	CcSEcCtD
Cisplatin—CYP2C9—digestive system—Crohn's disease	0.000192	0.00325	CbGeAlD
Cisplatin—Erythema—Mesalazine—Crohn's disease	0.000189	0.00253	CcSEcCtD
Cisplatin—Malaise—Azathioprine—Crohn's disease	0.000187	0.0025	CcSEcCtD
Cisplatin—Flatulence—Mesalazine—Crohn's disease	0.000186	0.00249	CcSEcCtD
Cisplatin—Leukopenia—Azathioprine—Crohn's disease	0.000186	0.00248	CcSEcCtD
Cisplatin—Cardiac failure congestive—Prednisone—Crohn's disease	0.000183	0.00245	CcSEcCtD
Cisplatin—Muscle spasms—Mesalazine—Crohn's disease	0.000182	0.00243	CcSEcCtD
Cisplatin—Vomiting—Mercaptopurine—Crohn's disease	0.000181	0.00241	CcSEcCtD
Cisplatin—Rash—Mercaptopurine—Crohn's disease	0.000179	0.00239	CcSEcCtD
Cisplatin—Dermatitis—Mercaptopurine—Crohn's disease	0.000179	0.00239	CcSEcCtD
Cisplatin—Vision blurred—Mesalazine—Crohn's disease	0.000178	0.00238	CcSEcCtD
Cisplatin—Tremor—Mesalazine—Crohn's disease	0.000177	0.00237	CcSEcCtD
Cisplatin—Amnesia—Prednisone—Crohn's disease	0.000177	0.00236	CcSEcCtD
Cisplatin—Myalgia—Azathioprine—Crohn's disease	0.000177	0.00236	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000176	0.00234	CcSEcCtD
Cisplatin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000176	0.00234	CcSEcCtD
Cisplatin—Anaemia—Mesalazine—Crohn's disease	0.000175	0.00233	CcSEcCtD
Cisplatin—Discomfort—Azathioprine—Crohn's disease	0.000175	0.00233	CcSEcCtD
Cisplatin—Malaise—Mesalazine—Crohn's disease	0.000171	0.00228	CcSEcCtD
Cisplatin—PTGS2—lymphoid tissue—Crohn's disease	0.00017	0.00287	CbGeAlD
Cisplatin—Leukopenia—Mesalazine—Crohn's disease	0.000169	0.00226	CcSEcCtD
Cisplatin—Nausea—Mercaptopurine—Crohn's disease	0.000169	0.00226	CcSEcCtD
Cisplatin—Infection—Azathioprine—Crohn's disease	0.000168	0.00225	CcSEcCtD
Cisplatin—PTGS2—digestive system—Crohn's disease	0.000167	0.00283	CbGeAlD
Cisplatin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000166	0.00222	CcSEcCtD
Cisplatin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000166	0.00222	CcSEcCtD
Cisplatin—Skin disorder—Azathioprine—Crohn's disease	0.000165	0.0022	CcSEcCtD
Cisplatin—ABCC2—lymph node—Crohn's disease	0.000165	0.00278	CbGeAlD
Cisplatin—Myalgia—Mesalazine—Crohn's disease	0.000161	0.00215	CcSEcCtD
Cisplatin—Anxiety—Mesalazine—Crohn's disease	0.00016	0.00214	CcSEcCtD
Cisplatin—Face oedema—Prednisone—Crohn's disease	0.00016	0.00214	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00016	0.00214	CcSEcCtD
Cisplatin—Discomfort—Mesalazine—Crohn's disease	0.000159	0.00212	CcSEcCtD
Cisplatin—Irritability—Prednisone—Crohn's disease	0.000159	0.00212	CcSEcCtD
Cisplatin—Hypotension—Azathioprine—Crohn's disease	0.000158	0.00211	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000154	0.00206	CcSEcCtD
Cisplatin—Oedema—Mesalazine—Crohn's disease	0.000154	0.00206	CcSEcCtD
Cisplatin—Anaphylactic shock—Mesalazine—Crohn's disease	0.000154	0.00206	CcSEcCtD
Cisplatin—Infection—Mesalazine—Crohn's disease	0.000153	0.00205	CcSEcCtD
Cisplatin—Nervous system disorder—Mesalazine—Crohn's disease	0.000151	0.00202	CcSEcCtD
Cisplatin—Hypokalaemia—Prednisone—Crohn's disease	0.000151	0.00202	CcSEcCtD
Cisplatin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000151	0.00202	CcSEcCtD
Cisplatin—Tachycardia—Mesalazine—Crohn's disease	0.000151	0.00201	CcSEcCtD
Cisplatin—Skin disorder—Mesalazine—Crohn's disease	0.00015	0.002	CcSEcCtD
Cisplatin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000149	0.00199	CcSEcCtD
Cisplatin—Anorexia—Mesalazine—Crohn's disease	0.000147	0.00196	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000146	0.00195	CcSEcCtD
Cisplatin—Hypotension—Mesalazine—Crohn's disease	0.000144	0.00193	CcSEcCtD
Cisplatin—Pancreatitis—Prednisone—Crohn's disease	0.000141	0.00188	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000141	0.00188	CcSEcCtD
Cisplatin—Sweating increased—Prednisone—Crohn's disease	0.00014	0.00187	CcSEcCtD
Cisplatin—Feeling abnormal—Azathioprine—Crohn's disease	0.00014	0.00186	CcSEcCtD
Cisplatin—Paraesthesia—Mesalazine—Crohn's disease	0.000139	0.00185	CcSEcCtD
Cisplatin—Dyspnoea—Mesalazine—Crohn's disease	0.000138	0.00184	CcSEcCtD
Cisplatin—ABCB1—epithelium—Crohn's disease	0.000136	0.0023	CbGeAlD
Cisplatin—Decreased appetite—Mesalazine—Crohn's disease	0.000134	0.00179	CcSEcCtD
Cisplatin—Body temperature increased—Azathioprine—Crohn's disease	0.000134	0.00179	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000133	0.00178	CcSEcCtD
Cisplatin—Pain—Mesalazine—Crohn's disease	0.000132	0.00176	CcSEcCtD
Cisplatin—Feeling abnormal—Mesalazine—Crohn's disease	0.000127	0.0017	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisone—Crohn's disease	0.000126	0.00169	CcSEcCtD
Cisplatin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000126	0.00168	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisone—Crohn's disease	0.000126	0.00168	CcSEcCtD
Cisplatin—Hypersensitivity—Azathioprine—Crohn's disease	0.000125	0.00167	CcSEcCtD
Cisplatin—BCHE—lymph node—Crohn's disease	0.000124	0.0021	CbGeAlD
Cisplatin—Body temperature increased—Mesalazine—Crohn's disease	0.000122	0.00163	CcSEcCtD
Cisplatin—ABCG2—lymph node—Crohn's disease	0.00012	0.00203	CbGeAlD
Cisplatin—ABCB1—mammalian vulva—Crohn's disease	0.000118	0.002	CbGeAlD
Cisplatin—Bradycardia—Prednisone—Crohn's disease	0.000117	0.00156	CcSEcCtD
Cisplatin—Diarrhoea—Azathioprine—Crohn's disease	0.000116	0.00155	CcSEcCtD
Cisplatin—Hypersensitivity—Mesalazine—Crohn's disease	0.000114	0.00152	CcSEcCtD
Cisplatin—Connective tissue disorder—Prednisone—Crohn's disease	0.000113	0.00151	CcSEcCtD
Cisplatin—Asthenia—Mesalazine—Crohn's disease	0.000111	0.00148	CcSEcCtD
Cisplatin—Vomiting—Azathioprine—Crohn's disease	0.000108	0.00144	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—Crohn's disease	0.000107	0.00143	CcSEcCtD
Cisplatin—Rash—Azathioprine—Crohn's disease	0.000107	0.00143	CcSEcCtD
Cisplatin—Dermatitis—Azathioprine—Crohn's disease	0.000107	0.00143	CcSEcCtD
Cisplatin—Flushing—Prednisone—Crohn's disease	0.000107	0.00142	CcSEcCtD
Cisplatin—Diarrhoea—Mesalazine—Crohn's disease	0.000106	0.00141	CcSEcCtD
Cisplatin—ABCB1—lymphoid tissue—Crohn's disease	0.000105	0.00177	CbGeAlD
Cisplatin—Immune system disorder—Prednisone—Crohn's disease	0.000104	0.00139	CcSEcCtD
Cisplatin—ABCB1—digestive system—Crohn's disease	0.000104	0.00175	CbGeAlD
Cisplatin—Arrhythmia—Prednisone—Crohn's disease	0.000103	0.00137	CcSEcCtD
Cisplatin—Alopecia—Prednisone—Crohn's disease	0.000102	0.00136	CcSEcCtD
Cisplatin—Nausea—Azathioprine—Crohn's disease	0.000101	0.00134	CcSEcCtD
Cisplatin—Erythema—Prednisone—Crohn's disease	0.0001	0.00134	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—Crohn's disease	0.0001	0.00134	CcSEcCtD
Cisplatin—Vomiting—Mesalazine—Crohn's disease	9.82e-05	0.00131	CcSEcCtD
Cisplatin—Rash—Mesalazine—Crohn's disease	9.73e-05	0.0013	CcSEcCtD
Cisplatin—Dermatitis—Mesalazine—Crohn's disease	9.72e-05	0.0013	CcSEcCtD
Cisplatin—PTGS2—lymph node—Crohn's disease	9.57e-05	0.00162	CbGeAlD
Cisplatin—Vision blurred—Prednisone—Crohn's disease	9.43e-05	0.00126	CcSEcCtD
Cisplatin—Ill-defined disorder—Prednisone—Crohn's disease	9.29e-05	0.00124	CcSEcCtD
Cisplatin—Anaemia—Prednisone—Crohn's disease	9.25e-05	0.00124	CcSEcCtD
Cisplatin—Nausea—Mesalazine—Crohn's disease	9.17e-05	0.00122	CcSEcCtD
Cisplatin—Malaise—Prednisone—Crohn's disease	9.02e-05	0.00121	CcSEcCtD
Cisplatin—Convulsion—Prednisone—Crohn's disease	8.67e-05	0.00116	CcSEcCtD
Cisplatin—Myalgia—Prednisone—Crohn's disease	8.52e-05	0.00114	CcSEcCtD
Cisplatin—Anxiety—Prednisone—Crohn's disease	8.49e-05	0.00113	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	8.46e-05	0.00113	CcSEcCtD
Cisplatin—Discomfort—Prednisone—Crohn's disease	8.42e-05	0.00112	CcSEcCtD
Cisplatin—Oedema—Prednisone—Crohn's disease	8.17e-05	0.00109	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—Crohn's disease	8.17e-05	0.00109	CcSEcCtD
Cisplatin—Infection—Prednisone—Crohn's disease	8.11e-05	0.00108	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—Crohn's disease	8.01e-05	0.00107	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—Crohn's disease	7.97e-05	0.00106	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—Crohn's disease	7.93e-05	0.00106	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisone—Crohn's disease	7.9e-05	0.00105	CcSEcCtD
Cisplatin—Anorexia—Prednisone—Crohn's disease	7.79e-05	0.00104	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—Crohn's disease	7.44e-05	0.000994	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—Crohn's disease	7.33e-05	0.000979	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—Crohn's disease	7.1e-05	0.000948	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—Crohn's disease	6.73e-05	0.000899	CcSEcCtD
Cisplatin—Body temperature increased—Prednisone—Crohn's disease	6.46e-05	0.000862	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisone—Crohn's disease	6.02e-05	0.000804	CcSEcCtD
Cisplatin—ABCB1—lymph node—Crohn's disease	5.92e-05	0.001	CbGeAlD
Cisplatin—Asthenia—Prednisone—Crohn's disease	5.86e-05	0.000783	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—Crohn's disease	5.59e-05	0.000746	CcSEcCtD
Cisplatin—Vomiting—Prednisone—Crohn's disease	5.19e-05	0.000693	CcSEcCtD
Cisplatin—Rash—Prednisone—Crohn's disease	5.15e-05	0.000688	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—Crohn's disease	5.15e-05	0.000687	CcSEcCtD
Cisplatin—Nausea—Prednisone—Crohn's disease	4.85e-05	0.000648	CcSEcCtD
Cisplatin—GSTM1—Metabolism—MTMR3—Crohn's disease	4.72e-05	0.000922	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—Crohn's disease	4.64e-05	0.000907	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PLA2G4F—Crohn's disease	4.6e-05	0.000899	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	4.59e-05	0.000897	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.47e-05	0.000874	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	4.43e-05	0.000865	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—STAT3—Crohn's disease	4.35e-05	0.00085	CbGpPWpGaD
Cisplatin—MT2A—Immune System—UBE2D1—Crohn's disease	4.35e-05	0.00085	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.34e-05	0.000848	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—ALB—Crohn's disease	4.3e-05	0.000841	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IL6—Crohn's disease	4.29e-05	0.000838	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.25e-05	0.000831	CbGpPWpGaD
Cisplatin—MT2A—Immune System—RIPK2—Crohn's disease	4.22e-05	0.000824	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ITGA4—Crohn's disease	4.22e-05	0.000824	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.2e-05	0.00082	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.2e-05	0.00082	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	4.19e-05	0.000819	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RSPO3—Crohn's disease	4.13e-05	0.000807	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PLA2G4F—Crohn's disease	4.12e-05	0.000806	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL3—Crohn's disease	4.11e-05	0.000804	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.06e-05	0.000794	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—MTMR3—Crohn's disease	4.01e-05	0.000784	CbGpPWpGaD
Cisplatin—MT2A—Immune System—RASGRP1—Crohn's disease	3.98e-05	0.000777	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD79A—Crohn's disease	3.96e-05	0.000775	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PLA2G4F—Crohn's disease	3.95e-05	0.000773	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SEL1L—Crohn's disease	3.91e-05	0.000765	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—MTMR3—Crohn's disease	3.91e-05	0.000764	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	3.9e-05	0.000762	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	3.89e-05	0.000761	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TAB1—Crohn's disease	3.89e-05	0.000761	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NOD2—Crohn's disease	3.82e-05	0.000747	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	3.81e-05	0.000745	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IL6—Crohn's disease	3.75e-05	0.000732	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.73e-05	0.000729	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—FADS1—Crohn's disease	3.68e-05	0.000719	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—ALB—Crohn's disease	3.66e-05	0.000715	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.65e-05	0.000713	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.65e-05	0.000713	CbGpPWpGaD
Cisplatin—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	3.63e-05	0.00071	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CXCL8—Crohn's disease	3.63e-05	0.00071	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	3.61e-05	0.000706	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	3.61e-05	0.000706	CbGpPWpGaD
Cisplatin—MT2A—Immune System—SOCS1—Crohn's disease	3.6e-05	0.000704	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL2RA—Crohn's disease	3.52e-05	0.000688	CbGpPWpGaD
Cisplatin—ABCC5—Disease—LTF—Crohn's disease	3.51e-05	0.000686	CbGpPWpGaD
Cisplatin—XDH—Metabolism—MTMR3—Crohn's disease	3.51e-05	0.000685	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—ALB—Crohn's disease	3.51e-05	0.000685	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.51e-05	0.000685	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	3.5e-05	0.000685	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL10—Crohn's disease	3.5e-05	0.000685	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GPX4—Crohn's disease	3.44e-05	0.000673	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.44e-05	0.000673	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PLA2G4F—Crohn's disease	3.43e-05	0.00067	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—IL6—Crohn's disease	3.39e-05	0.000662	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—MTMR3—Crohn's disease	3.36e-05	0.000657	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GCKR—Crohn's disease	3.32e-05	0.00065	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.31e-05	0.000648	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.3e-05	0.000644	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL18—Crohn's disease	3.24e-05	0.000634	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CXCL8—Crohn's disease	3.17e-05	0.000619	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—FADS1—Crohn's disease	3.13e-05	0.000611	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	3.12e-05	0.00061	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	3.1e-05	0.000607	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.1e-05	0.000606	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—FADS1—Crohn's disease	3.05e-05	0.000595	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL6—Crohn's disease	3.04e-05	0.000594	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.96e-05	0.000578	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GPX4—Crohn's disease	2.93e-05	0.000572	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.93e-05	0.000572	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	2.92e-05	0.000571	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—STAT3—Crohn's disease	2.92e-05	0.000571	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—MTMR3—Crohn's disease	2.91e-05	0.00057	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PLA2G4F—Crohn's disease	2.91e-05	0.00057	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.9e-05	0.000567	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	2.89e-05	0.000565	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2RA—Crohn's disease	2.88e-05	0.000563	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GPX4—Crohn's disease	2.85e-05	0.000558	CbGpPWpGaD
Cisplatin—ABCC5—Disease—GCKR—Crohn's disease	2.83e-05	0.000553	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GCKR—Crohn's disease	2.83e-05	0.000553	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	2.77e-05	0.000542	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GCKR—Crohn's disease	2.75e-05	0.000538	CbGpPWpGaD
Cisplatin—XDH—Metabolism—FADS1—Crohn's disease	2.73e-05	0.000534	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CRP—Crohn's disease	2.72e-05	0.000531	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	2.71e-05	0.00053	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	2.67e-05	0.000522	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	2.67e-05	0.000521	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.66e-05	0.00052	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—FADS1—Crohn's disease	2.62e-05	0.000512	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.61e-05	0.000511	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TLR4—Crohn's disease	2.6e-05	0.000509	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.57e-05	0.000502	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GPX4—Crohn's disease	2.56e-05	0.0005	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—STAT3—Crohn's disease	2.55e-05	0.000498	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	2.54e-05	0.000497	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—ALB—Crohn's disease	2.54e-05	0.000497	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SLC11A1—Crohn's disease	2.5e-05	0.000489	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ICAM1—Crohn's disease	2.5e-05	0.000488	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MTMR3—Crohn's disease	2.48e-05	0.000484	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GCKR—Crohn's disease	2.47e-05	0.000483	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GPX4—Crohn's disease	2.45e-05	0.000479	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	2.38e-05	0.000465	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GCKR—Crohn's disease	2.37e-05	0.000463	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—JAK2—Crohn's disease	2.36e-05	0.000462	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.28e-05	0.000446	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.28e-05	0.000446	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.27e-05	0.000444	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—FADS1—Crohn's disease	2.27e-05	0.000444	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.25e-05	0.00044	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PLA2G4F—Crohn's disease	2.23e-05	0.000435	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.2e-05	0.00043	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RBX1—Crohn's disease	2.14e-05	0.000419	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HSPA1B—Crohn's disease	2.14e-05	0.000419	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.13e-05	0.000417	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GPX4—Crohn's disease	2.13e-05	0.000416	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	2.11e-05	0.000412	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	2.06e-05	0.000403	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GCKR—Crohn's disease	2.05e-05	0.000401	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—Crohn's disease	2.04e-05	0.000399	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TYK2—Crohn's disease	2.03e-05	0.000397	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PLA2G4F—Crohn's disease	2.01e-05	0.000393	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PLA2G4F—Crohn's disease	1.99e-05	0.000389	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	1.97e-05	0.000386	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	1.97e-05	0.000386	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.96e-05	0.000383	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.94e-05	0.000379	CbGpPWpGaD
Cisplatin—MT2A—Immune System—JAK2—Crohn's disease	1.94e-05	0.000378	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—FADS1—Crohn's disease	1.93e-05	0.000377	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	1.92e-05	0.000374	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFNG—Crohn's disease	1.9e-05	0.000371	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTMR3—Crohn's disease	1.89e-05	0.00037	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.88e-05	0.000368	CbGpPWpGaD
Cisplatin—ABCC5—Disease—UBE2D1—Crohn's disease	1.88e-05	0.000367	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	1.84e-05	0.000359	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—Crohn's disease	1.84e-05	0.000359	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GPX4—Crohn's disease	1.81e-05	0.000353	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—Crohn's disease	1.78e-05	0.000348	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GCKR—Crohn's disease	1.75e-05	0.000341	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.73e-05	0.000337	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTMR3—Crohn's disease	1.71e-05	0.000334	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1B—Crohn's disease	1.69e-05	0.000331	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTMR3—Crohn's disease	1.69e-05	0.000331	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ALB—Crohn's disease	1.64e-05	0.000321	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ALB—Crohn's disease	1.61e-05	0.000315	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RSPO3—Crohn's disease	1.6e-05	0.000313	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	1.59e-05	0.000311	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.53e-05	0.0003	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SEL1L—Crohn's disease	1.52e-05	0.000296	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.51e-05	0.000295	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—FADS1—Crohn's disease	1.48e-05	0.000288	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	1.47e-05	0.000288	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.47e-05	0.000287	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—Crohn's disease	1.44e-05	0.000281	CbGpPWpGaD
Cisplatin—MT2A—Immune System—STAT3—Crohn's disease	1.42e-05	0.000278	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.41e-05	0.000276	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.39e-05	0.000272	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.39e-05	0.000272	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GPX4—Crohn's disease	1.38e-05	0.00027	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.36e-05	0.000267	CbGpPWpGaD
Cisplatin—PTGS2—Disease—LTF—Crohn's disease	1.36e-05	0.000266	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SMAD3—Crohn's disease	1.34e-05	0.000263	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GCKR—Crohn's disease	1.33e-05	0.000261	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—Crohn's disease	1.33e-05	0.000261	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—FADS1—Crohn's disease	1.33e-05	0.00026	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—FADS1—Crohn's disease	1.32e-05	0.000258	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTMR3—Crohn's disease	1.3e-05	0.000255	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.28e-05	0.000251	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTMR3—Crohn's disease	1.25e-05	0.000245	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.25e-05	0.000244	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GPX4—Crohn's disease	1.25e-05	0.000244	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GPX4—Crohn's disease	1.23e-05	0.000241	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.23e-05	0.00024	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GCKR—Crohn's disease	1.2e-05	0.000235	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GCKR—Crohn's disease	1.19e-05	0.000233	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	1.19e-05	0.000232	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	1.1e-05	0.000215	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GCKR—Crohn's disease	1.1e-05	0.000214	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.09e-05	0.000213	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.09e-05	0.000212	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ALB—Crohn's disease	1.06e-05	0.000207	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—FADS1—Crohn's disease	1.02e-05	0.000198	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.02e-05	0.000198	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—Crohn's disease	9.92e-06	0.000194	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—FADS1—Crohn's disease	9.76e-06	0.000191	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	9.75e-06	0.000191	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC11A1—Crohn's disease	9.69e-06	0.000189	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	9.53e-06	0.000186	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPX4—Crohn's disease	9.51e-06	0.000186	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	9.41e-06	0.000184	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.28e-06	0.000181	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—Crohn's disease	9.26e-06	0.000181	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTMR3—Crohn's disease	9.24e-06	0.000181	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GCKR—Crohn's disease	9.18e-06	0.00018	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPX4—Crohn's disease	9.14e-06	0.000179	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ALB—Crohn's disease	9e-06	0.000176	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GCKR—Crohn's disease	8.83e-06	0.000173	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TYK2—Crohn's disease	8.77e-06	0.000171	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ALB—Crohn's disease	8.77e-06	0.000171	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTMR3—Crohn's disease	8.63e-06	0.000169	CbGpPWpGaD
Cisplatin—ABCC5—Disease—JAK2—Crohn's disease	8.37e-06	0.000164	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.34e-06	0.000163	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RBX1—Crohn's disease	8.31e-06	0.000162	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HSPA1B—Crohn's disease	8.31e-06	0.000162	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.18e-06	0.00016	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	8.1e-06	0.000158	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—Crohn's disease	7.93e-06	0.000155	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—Crohn's disease	7.87e-06	0.000154	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—Crohn's disease	7.87e-06	0.000154	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ALB—Crohn's disease	7.86e-06	0.000154	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—Crohn's disease	7.67e-06	0.00015	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ALB—Crohn's disease	7.54e-06	0.000147	CbGpPWpGaD
Cisplatin—PTGS2—Disease—UBE2D1—Crohn's disease	7.29e-06	0.000142	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FADS1—Crohn's disease	7.2e-06	0.000141	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	6.99e-06	0.000137	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—Crohn's disease	6.88e-06	0.000134	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPX4—Crohn's disease	6.74e-06	0.000132	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FADS1—Crohn's disease	6.72e-06	0.000131	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—Crohn's disease	6.59e-06	0.000129	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.58e-06	0.000129	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.56e-06	0.000128	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ALB—Crohn's disease	6.54e-06	0.000128	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GCKR—Crohn's disease	6.51e-06	0.000127	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPX4—Crohn's disease	6.3e-06	0.000123	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—Crohn's disease	6.14e-06	0.00012	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GCKR—Crohn's disease	6.08e-06	0.000119	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—Crohn's disease	5.72e-06	0.000112	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—Crohn's disease	5.56e-06	0.000109	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SMAD3—Crohn's disease	5.21e-06	0.000102	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—Crohn's disease	4.86e-06	9.5e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.42e-06	8.65e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.35e-06	8.49e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—Crohn's disease	4.29e-06	8.39e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—Crohn's disease	4.25e-06	8.3e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—Crohn's disease	3.83e-06	7.49e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.8e-06	7.43e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—Crohn's disease	3.79e-06	7.41e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—Crohn's disease	3.71e-06	7.26e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TYK2—Crohn's disease	3.4e-06	6.65e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—Crohn's disease	3.35e-06	6.55e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—Crohn's disease	3.32e-06	6.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JAK2—Crohn's disease	3.24e-06	6.34e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—Crohn's disease	3.08e-06	6.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—Crohn's disease	2.92e-06	5.71e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—Crohn's disease	2.81e-06	5.49e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—Crohn's disease	2.46e-06	4.8e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—Crohn's disease	2.38e-06	4.65e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—Crohn's disease	2.07e-06	4.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—Crohn's disease	1.94e-06	3.78e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—Crohn's disease	1.81e-06	3.54e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.69e-06	3.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—Crohn's disease	1.66e-06	3.25e-05	CbGpPWpGaD
